Morphic Therapeutic Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Employees
-
128
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$2.05B
Morphic Therapeutic General Information
Description
Operator of a biopharmaceutical company developing oral integrin therapies for the treatment of serious chronic diseases. The company specializes in applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics to the Integrins target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis and cancer.
Contact Information
Website
www.morphictx.comCorporate Office
- 35 Gatehouse Drive, A2
- Waltham, MA 02451
- United States
Corporate Office
- 35 Gatehouse Drive, A2
- Waltham, MA 02451
- United States
Morphic Therapeutic Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 16-Aug-2024 | $2.05B | Completed | Generating Revenue | ||
| 7. 2PO | 26-Apr-2024 | Completed | Generating Revenue | |||
| 6. PIPE | 15-Feb-2023 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Open Market | 11-Feb-2020 | Completed | Generating Revenue | |||
| 4. IPO | 27-Jun-2019 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 25-Sep-2018 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 30-Jun-2016 | $51.5M | $58M | Completed | Generating Revenue | |
| 1. Seed Round | 01-Jun-2015 | $6.5M | $6.5M | Completed | Generating Revenue |
Morphic Therapeutic Comparisons
Industry
Financing
Details
Morphic Therapeutic Competitors (66)
One of Morphic Therapeutic’s 66 competitors is Pliant Therapeutics, a Formerly VC-backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pliant Therapeutics | Formerly VC-backed | San Francisco, CA | ||||
| Madrigal Pharmaceuticals | Formerly VC-backed | West Conshohocken, PA | ||||
| Sarepta Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Galectin Therapeutics | Corporation | Norcross, GA | ||||
| Symphogen | Formerly VC-backed | Ballerup, Denmark |
Morphic Therapeutic Signals
Morphic Therapeutic Former Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AbbVie Ventures | Corporate Venture Capital | Minority | ||
| ChemPartner | Corporation | Minority | ||
| EcoR1 Capital | Venture Capital | Minority | ||
| GSK | Corporation | Minority | ||
| Invus (Private Equity) | PE/Buyout | Minority |
Morphic Therapeutic ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
34.48 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Biotechnology
Subindustry
of 431
Rank
Percentile
Morphic Therapeutic FAQs
-
When was Morphic Therapeutic founded?
Morphic Therapeutic was founded in 2014.
-
Where is Morphic Therapeutic headquartered?
Morphic Therapeutic is headquartered in Waltham, MA.
-
What is the size of Morphic Therapeutic?
Morphic Therapeutic has 128 total employees.
-
What industry is Morphic Therapeutic in?
Morphic Therapeutic’s primary industry is Drug Discovery.
-
Is Morphic Therapeutic a private or public company?
Morphic Therapeutic is a Private company.
-
What is the current valuation of Morphic Therapeutic?
The current valuation of Morphic Therapeutic is .
-
What is Morphic Therapeutic’s current revenue?
The current revenue for Morphic Therapeutic is .
-
How much funding has Morphic Therapeutic raised over time?
Morphic Therapeutic has raised $568M.
-
Who are Morphic Therapeutic’s investors?
AbbVie Ventures, ChemPartner, EcoR1 Capital, GSK, and Invus (Private Equity) are 5 of 16 investors who have invested in Morphic Therapeutic.
-
Who are Morphic Therapeutic’s competitors?
Pliant Therapeutics, Madrigal Pharmaceuticals, Sarepta Therapeutics, Galectin Therapeutics, and Symphogen are some of the 66 competitors of Morphic Therapeutic.
-
When was Morphic Therapeutic acquired?
Morphic Therapeutic was acquired on 16-Aug-2024.
-
Who acquired Morphic Therapeutic?
Morphic Therapeutic was acquired by Lilly USA.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process